Joincare Pharmaceutical Group Industry Co., Ltd | ClinicalTrials HQ

5 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
A Phase 2 Trial of JKN24011 in COPD	Chronic Disease, Disease Attributes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, chronic obstructive pulmonary disease, lung disorder, obstructive lung disease, respiratory system disorder	Active, not recruiting	Phase 2	2026-02-27		NCT07440524
Phase III Clinical Study Evaluating the Safety, Pharmacokinetics, and Efficacy of JKN2301 Dry Suspension in Pediatric Patients Aged 2 to Under 12 Years With Influenza	Respiratory Viral Infection	Recruiting	Phase 3	2026-01-21		NCT07357051
A Phase IIa, Randomized, Double-Blind, Placebo-Controlled Trial of JKN2403 in COPD	Chronic Disease, Disease Attributes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, chronic obstructive pulmonary disease, lung disorder, obstructive lung disease, respiratory system disorder	Recruiting	Phase 2	2026-01-20		NCT07351734
A Phase 3 Trial of JKN2401 Injection in COPD	Chronic Disease, Disease Attributes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, chronic obstructive pulmonary disease, lung disorder, obstructive lung disease, respiratory system disorder	Not yet recruiting	Phase 3	2026-01-14		NCT07330310
Phase I Study of Single/Multiple Ascending Doses of JKN2501 for Injection in Chinese Healthy Volunteers	Bacterial Infections and Mycoses, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Infections, Intraabdominal Infections, Male Urogenital Diseases, Urogenital Diseases, bacterial infectious disease, respiratory system disorder, respiratory tract infectious disorder, urinary system disorder, urinary tract infection	Recruiting	Phase 1	2025-10-03		NCT07207291